Two newer approaches to management of major hemorrhage missed the mark in randomized clinical trials published in a special transfusion-related issue of JAMA. In the CRYOSTAT-2 trial, adding early, ...

For patients with nontraumatic, out-of-hospital cardiac arrest (OHCA), evolving technology in the form of resuscitative endovascular balloon occlusion of the aorta, as well as expanded use of ...

San Antonio, TX ., Pryor Medical Devices (The REBOA Company TM), today announced it has received FDA 510(k) clearance for the sale and distribution of its ER-REBOA TM catheter. REBOA (Resuscitative ...

LONDON, ON, Jan. 23, 2025 /PRNewswire/ -- Front Line Medical Technologies, a leader in innovative medical devices for emergency and trauma care, announces the UK launch of its CE-marked COBRA-OS ®, ...

Dr. Chance Spalding uses the REBOA technique to help victims of car crashes or shootings at Grant Medical Center. A small balloon could be one of the best bets for Columbus doctors to save gunshot ...

BOERNE, Texas, Jan. 7, 2025 /PRNewswire/ -- Prytime Medical, The REBOA Company™, proudly announces the first civilian use of its pREBOA-PRO™ catheter in the European Union, following the device's ...

BOERNE, Texas, May 24, 2021 /CNW/ -- Prytime Medical Devices, Inc. announced today it has received both UK and CE Mark Approval for its next-generation ER-REBOA PLUS™ Catheter. Designed for improved ...

LONDON, Ontario – Sept. 10, 2021 – Excessive blood loss is one of the leading causes of death in trauma patients, and trauma is the fourth leading cause of death overall for all ages. That’s where ...